Das Medizinportal


Interventionelle Therapie der thorakalen Aorta

Chris Probst, Wolfgang Scgiller, Fritz Mellert, Armin Welz

  1. Parodi,JC, Palmaz,JC, BaroneHD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991; 5: 491–499
  2. Dake MD, Miller DC, Semba CP, et al. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 1994; 331:1729–34. ?
  3. Dake MD, Kato N, Mitchell RS, et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med 1999; 340:1546–52.
  4. Meszaros I, Morocz J, Szlavi J et al. Epidemiology and clinico? pahtology of aortic dissection. Chest 2000; 117: 1271–1278 ?
  5. Bickerstaff LK, Pairolero PC, Hollier LH et al. Thoracic aortic aneurysms:a population?based study. Surgery 1982; 92: 1103–1108 ?
  6. Clouse WD, Hallett JW Jr, Schaff HV et al. Acute aortic disection: population?based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc 2004; 79: 176–180
  7. Rehders TC, Ince H, Schneider H, Chatterjee T, Nienaber CA. Diagnostisches und therapeutisches Management bei akutem Aortensyndrom   Kardiologie up2date, 2006; 75–88
  8. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Erbel R et al ESC Committee for Practice Guidelines. Eur Heart J. 2014; 35(41):2873–926.
  9. Nienaber CA, Zannetti S, Barbieri B, Kische S, Schareck W, Rehders TC: Investigation of STEnt grafts in patients with type B aortic Dissection: Design of the INSTEAD trial—a prospective, multicenter European randomized trial. Am Heart J 2005; 149: 592–599,
  10. Januzzi JL, Eagle KA, Cooper JV, Fang J, Sechtem U, Myrmel T, Evangelista A, Oh JK, Llovet A, O’Gara PT, Nienaber CA, Isselbacher EM. Acute aortic dissection presenting with congestive heart failure: results from the International Registry of Acute Aortic Dissection. J Am Coll Cardiol 2005; 46: 733–735.
  11. Rylski B, Hoffmann I, Beyersdorf F, Suedkamp M, Siepe M, Nitsch B, Blettner M, Borger MA, Weigang E; Acute aortic dissection type A: age-related management and outcomes reported in the German Registry for Acute Aortic Dissection Type A (GERAADA) of over 2000 patients.; Ann Surg. 2014; 259(3): 598–604
  12. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010
  13. Grabenwoger M, Alfonso F, Bachet J, Bonser R, Czerny M, Eggebrecht H, Evangelista A, Fattori R, Jakob H, Lonn L, Nienaber CA, Rocchi G, Rousseau H, Thompson M, Weigang E, Erbel R. Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: a position statement from the Euro- pean Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutan- eous Cardiovascular Interventions (EAPCI). Eur Heart J 2012; 33: 1558–1563. ;121:e266–e369.
  14. 14 . Svensson LG, Kouchoukos NT, Miller DC, et al: Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg 2008; 85: 1–41,
  15. Nienaber CA, Kische S, Rousseau H, et al. Endovascular repair of type B aortic dissection: long-term results of the Randomized Investigation of Stent Grafts in Aortic Dissection Trial. Circ Cardiovasc Interv 2013; 6: 407–16. ?
  16. Abbé R.: The surgery of the hand. NY Med J 1894; 59: 33
  17. Voss B, Bauernschmitt R, Brockmann G, Lange R; Minimalinvasive endovaskuläre Stent-Therapie bei Erkrankungen in der thorakalen Aorta ; Kapitel 50. E. Wintermantel • S.-W. Ha Medizintechnik – Life Science Engineering
  18. Koeppel TA, Greiner A, Jacobs MJ. Thorakale und thorakoabdominelle Aortenaneurysmen  DGG-Leitlinie 2010
  19. Goldyn G.L. Praxishandbuch Angiographie 2. Auflage Springer Verlag Kap. 4 S. 174-180
  20. Moon MC, Greenberg RK, Morales JP, et al. Computed tomography- based anatomic characterization of proximal aortic dissection with consideration for endovascular candidacy. J Vasc Surg 2011; 53: 942–9.
  21. Czerny M, Eggebrecht H, Sodeck G, et al. Mechanisms of symptomatic spinal cord ischemia after TEVAR: insights from the European Registry of Endovascular Aortic Repair Complications (EuREC). J Endovasc Ther 2012; 19: 37–43.
  22. Boodhwani M. et al.? Canadian Cardiovascular Society Position Statement on the Management of Thoracic Aortic Disease;  ; Canadian Journal of Cardiology 30 2014; 577–589
  23. Appoo JJ? et al; Thoracic Aortic Frontier: Review of Current Applications and Directions of Thoracic Endovascular Aortic Repair (TEVAR); Canadian Journal of Cardiology 30 8 2014; 52–63
  24. White GH, Yu W, May J.; Endoleak--a proposed new terminology to describe incomplete aneurysm exclusion by an endoluminal graft.; J Endovasc Surg. 1996;3(1):124–5

Periphere Gefäßchirurgie – aktuelle Techniken und Ergebnisse

Achim Neufang

  1. European Stroke O, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, et al. Esc guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The task force on the diagnosis and treatment of peripheral artery diseases of the european society of cardiology (esc). European heart journal. 2011; 32: 2851–2906
  2. Biancari F. Meta-analysis of the prevalence, incidence and natural history of critical limb ischemia. J Cardiovasc Surg (Torino). 2013; 54: 663–669
  3. Bradbury AW. Bypass versus angioplasty in severe ischaemia of the leg (basil) trial: What are its implications? Semin Vasc Surg. 2009; 22: 267–274
  4. Dorweiler B, Neufang A, Kreitner KF, Schmiedt W, Oelert H. Magnetic resonance angiography unmasks reliable target vessels for pedal bypass grafting in patients with diabetes mellitus. J Vasc Surg. 2002; 35: 766–772
  5. Sultan S, Tawfick W, Hynes N. Ten-year technical and clinical outcomes in transatlantic inter-society consensus ii infrainguinal c/d lesions using duplex ultrasound arterial mapping as the sole imaging modality for critical lower limb ischemia. J Vasc Surg. 2013; 57: 1038–1045
  6. Lawrence PF, Chandra A. When should open surgery be the initial option for critical limb ischaemia? Eur J Vasc Endovasc Surg. 2010; 39 Suppl 1: 32–37
  7. Ballotta E, Gruppo M, Mazzalai F, Da Giau G. Common femoral artery endarterectomy for occlusive disease: An 8-year single-center prospective study. Surgery. 2010;147:268-274
  8. Piazza M, Ricotta JJ, 2nd, Bower TC, Kalra M, Duncan AA, Cha S, et al. Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease. J Vasc Surg. 2011; 54: 402–411
  9. Gisbertz SS, Tutein Nolthenius RP, de Borst GJ, van der Laan L, Overtoom TT, Moll FL, et al. Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: Medium-term results of a randomized controlled trial (the revas trial). Ann Vasc Surg. 2010; 24: 1015–1023
  10. Gabrielli R, Rosati MS, Vitale S, Baciarello G, Siani A, Chiappa R, et al. Randomized controlled trial of remote endarterectomy versus endovascular intervention for transatlantic inter-society consensus ii d femoropopliteal lesions. J Vasc Surg. 2012; 56: 1598–1605
  11. Veith FJ, Gupta SK, Wengerter KR, Goldsmith J, Rivers SP, Bakal CW, et al. Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia. Ann Surg. 1990; 212: 402–412; discussion 412–404.
  12. Albers M, Romiti M, Brochado-Neto FC, De Luccia N, Pereira CA. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg. 2006; 43: 498–503
  13. Curi MA, Skelly CL, Woo DH, Desai TR, Katz D, McKinsey JF, et al. Long-term results of infrageniculate bypass grafting using all-autogenous composite vein. Ann Vasc Surg. 2002; 16: 618–623
  14. Arvela E, Soderstrom M, Alback A, Aho PS, Venermo M, Lepantalo M. Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia. J Vasc Surg. 2010; 52: 616–623
  15. Vauclair F, Haller C, Marques-Vidal P, Deglise S, Haesler E, Corpataux JM, et al. Infrainguinal bypass for peripheral arterial occlusive disease: When arms save legs. Eur J Vasc Endovasc Surg. 2012; 43: 48–53
  16. Taylor SM, Langan EM, 3rd, Snyder BA, Crane MM. Superficial femoral artery eversion endarterectomy: A useful adjunct for infrainguinal bypass in the presence of limited autogenous vein. J Vasc Surg. 1997; 26: 439–445; discussion 445–436
  17. Jauhari YA, Hughes CO, Black SA, Jones KG, Hinchliffe RJ, Thompson MM, et al. Endoscopic vein harvesting in lower extremity arterial bypass: A systematic review. Eur J Vasc Endovasc Surg. 2014; 47: 621–639
  18. Arvela E, Kauhanen P, Alback A, Lepantalo M, Neufang A, Adili F, et al. Initial experience with a new method of external polyester scaffolding for infrainguinal vein grafts. Eur J Vasc Endovasc Surg. 2009; 38: 456–462
  19. Reed AB. Hybrid procedures and distal origin grafts. Semin Vasc Surg. 2009; 22: 240–244
  20. Meyer A, Goller K, Horch RE, Beier JP, Taeger CD, Arkudas A, et al. Results of combined vascular reconstruction and free flap transfer for limb salvage in patients with critical limb ischemia. J Vasc Surg. 2015; 61: 1239–1248
  21. Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. The joint vascular research group. J Vasc Surg. 1997; 26: 543–550
  22. Lindholt JS, Gottschalksen B, Johannesen N, Dueholm D, Ravn H, Christensen ED, et al. The scandinavian propaten((r)) trial - 1-year patency of ptfe vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure ptfe vascular prostheses - a randomised clinical controlled multi-centre trial. Eur J Vasc Endovasc Surg. 2011; 41: 668–673
  23. Neufang A, Dorweiler B, Espinola-Klein C, Savvidis S, Doemland M, Schotten S, et al. Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J Vasc Surg. 2014; 60: 1543–1553
  24. Hartranft CA, Noland S, Kulwicki A, Holden CR, Hartranft T. Cryopreserved saphenous vein graft in infrainguinal bypass. J Vasc Surg. 2014; 60: 1291–1296
  25. Neville RF, Dy B, Singh N, DeZee KJ. Distal vein patch with an arteriovenous fistula: A viable option for the patient without autogenous conduit and severe distal occlusive disease. J Vasc Surg. 2009; 50: 83–88
  26. Ballotta E, Da Giau G, Gruppo M, Mazzalai F, Martella B, Militello C, et al. Revascularization to an isolated ("blind") popliteal artery segment: A viable procedure for critical limb ischemia. Surgery. 2009; 145: 426–434
  27. Mutirangura P, Ruangsetakit C, Wongwanit C, Sermsathanasawadi N, Chinsakchai K. Pedal bypass with deep venous arterialization: The therapeutic option in critical limb ischemia and unreconstructable distal arteries. Vascular. 2011; 19: 313–319

Die Therapie aortoiliakaler Gefäßläsionen im Wandel der Zeit

Ulrich Kusenack

  1. Böckler D, Burger U, Klemm K, Hyhlik-Dürr A. Geschlechtsverteilung aortaler Gefäßerkrankungen. Gefässchirurgie. 2007;12(6): 421–8.
  2. Naundorf M. Femoro-popliteale Gefäßverschlüsse. In: Luther B, editor. Kompaktwissen Gefäßchirurgie. 2. Heidelberg: Springer Medizin Verlag; 2011. 253–72.
  3. Kuhlencordt PJ, Bley T. Vaskuläre Untersuchungsmethoden. In: Debus ES, Gross-Fengels W, editors. Operative und interventionelle Gefäßmedizin. Berlin Heidelberg: Springer Medizin; 2012. 185–213.
  4. Schäberle W. Ultraschalldiagnostik in der Gefäßchirurgie / Teil 2: Periphere Venen, extrakranielle hirnversorgende Arterien. Ultrasound diagnostics in vascular surgery. Part II: peripheralveins and extracranial arteries feeding the brain. Gefässchirurgie. 2008;13(4): 59–71.
  5. Lawall H, Diehm C. Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK): Vasa; 2009; 38 (Suppl. 75).
  6. Rieß HC, Carpenter SW, Kosan J, Larena-Avellaneda A, Debus ES. Operative und interventionelle Therapie aortoiliakaler Gefäßverschlüsse. Gefäßmedizin Scan. 2014;1(1): 53–68.
  7. Böhner H, Klemp U, Pourhassan S, Pillny M, Aleksic M, Nowak T, et al. CME Zertifizierte Fortbildung. Review Articles. Konservative Therapie der peripheren arteriellen Verschlusskrankheit. Conservative treatment of peripheral arterial occlusive disease / Fragebogen. Questionnaire. Gefässchirurgie. 2012;17(3): 219–26.
  8. Kolvenbach R. Aorto-iliakale Gefäßverschlüsse. In: Luther B, editor. Kompaktwissen Gefäßchirurgie. 2. Heidelberg: Springer Medizin Verlag; 2011. 221–37.
  9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of vascular surgery. 2007;45 Suppl S: 5–67.
  10. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997;204(1): 87–96.
  11. Langkau GH, Kyek-Kübler H. Bauchaorten- und Beckenarterienverschlüsse (S2). In: Gefäßchirurgie DGf, editor. Leitlinien zu Diagnostik und Therapie in der Gefäßchirurgie. Heidelberg: Springer Medizin Verlag; 2010. p. 81–90.
  12. Mwipatayi BP, Thomas S, Wong J, Temple SEL, Vijayan V, Jackson M, et al. A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease. Journal of vascular surgery. 2011;54(6):1561–70.
  13. Goverde PCJM, Grimme FAB, Verbruggen PJEM, Reijnen MMPJ. Covered endovascular reconstruction of aortic bifurcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease. The Journal of cardiovascular surgery. 2013;54(3):383–7.
  14. Herten M, Stahlhoff S, Bisdas T, Donas K, Schwindt A, Torselio G, et al. Medikamentenbeschichtete Ballonkatheter in der Behandlung der peripheren arteriellen Verschlusskrankheit. Entwicklung der Methode und aktuelle Studienlage. Drug-coated balloon catheters in the treatment of peripheral arterial occlusive disease. Development of methods and current level of evidence. Gefässchirurgie. 2013;18(6): 520–32.
  15. Task Force for Preoperative Cardiac Risk A, Perioperative Cardiac Management in Non-cardiac S, European Society of C, Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. European heart journal. 2009;30(22): 2769–812.
  16. Schmedt C-G, Sadeghi-Azandaryani M, Steckmeier BM. Operative und endovaskuläre Therapie der aortoiliakalen Strombahn. Gefässchirurgie. 2007;12(4):253–68.
  17. Balzer KM. A. iliaca. In: Luther B, editor. Techniken der offenen Gefäßchirurgie. Berlin Heidelberg: Springer Medizin; 2014. 243–65.
  18. Kusenack U, Kamper L, Haage P, Zirngibl H, Meletiadis K. Junge Frauen - Problempatientinnen in der Gefäßchirurgie. Zentralblatt fur Chirurgie. 2015;140(in press).
  19. Quain R. Partial contraction of the abdominal aorta. Trans Pathol Soc London. 1848;1: 244–5.
  20. Schermerhorn ML, Giles KA. Population-based Comparison of Open repair and EVAR. In: Morasch MD, Pearce WH, Yao JST, editors. Surgery of the Aorta and Its Body Branches. 1. Shelton, Connecticut, USA: People´s Medical Publishing House - USA; 2010. 159–71.
  21. Gussmann A, Kühn J, Weise U. Bauchaortenaneurysma und Beckenarterienaneurysma (S2). In: Gefäßchirurgie DGf, editor. Leitlinien zu Diagnostik und Therapie in der Gefäßchirurgie. Heidelberg: Springer Medizin Verlag; 2010.73–80.
  22. Debus ES, Carpenter W, Larena-Avellaneda A, Kölbel T. Der Chimney-Graft als Alternative zur aortalen Custom-made-Prothese. Chimney graft as alternative to custom made aortic prosthesis. Gefässchirurgie. 2012;17(7): 626–31.
  23. Pfister K, Kasprzak PM, Apfelbeck H, Blazkow-Schmalzbauer K, Kopp R, Janotta M. Kontrastmittelsonographie nach EVAR. Technische Voraussetzung, Durchführung und Beurteilung aus praktischer Sicht. Contrast-enhanced ultrasound after EVAR. Technical requirements, implementation, and evaluation from a practical perspective. Gefässchirurgie. 2013;18(8): 722–7.
  24. Bünger CM, Eisold S, Klar E, Schareck W. CME. Zertifizierte Fortbildung. Review Articles. Randomisierte Studienlage zur Therapie des Bauchaortenaneurysmas. Vergleich zwischen endovaskulärem (EVAR) und operativem Vorgehen (OAR). Randomized controlled trials on treatment of abdominal aortic aneurysms. Comparison of endovascular (EVAR) and conventional procedures (OAR) / Fragebogen. Questionnaire. Gefässchirurgie. 2013;18(8): 743–57.
  25. Kortmann H. Aorta abdominalis. In: Luther B, editor. Techniken der offenen Gefäßchirurgie. Berlin Heidelberg: Springer Medizin; 2014. 153–97.

Endovaskuläre Therapie bei insuffizientem Dialyseshunt

Lars Kamper, Patrick Haage

  1. Stolic R. Most Important Chronic Complications of Arteriovenous Fistulas for Hemodialysis. Med Princ Pract. 2013; 22(3): 220–8.
  2. Mickley V. Stenosis and thrombosis in haemodialysis fistulae and grafts: the surgeon’s point of view. Nephrol Dial Transplant. 2. Januar 2004;19(2):309–11.
  3. Sivanesan S, How TV, Bakran A. Sites of stenosis in AV fistulae for haemodialysis access. Nephrol Dial Transplant. 1. Januar 1999; 14(1): 118–20.
  4. Kamper DL, Meletiadis K, Kusenack U, Haage P. Zentralvenöse Obstruktionen bei Patienten mit Dialyseshunt. Gefässchirurgie. 1. Dezember 2014; 19(8): 709–17.
  5. Kamper L, Faizy TD, Haage P. Leitliniengerechte Diagnostik und Therapie bei insuffizienten Dialyseshunts. RöFo Fortschritte Auf Dem Geb Röntgenstrahlen Nukl.
  6. Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, u. a. EBPG on Vascular Access. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. Mai 2007; 22 Suppl 2: ii88–117.
  7. Turmel-Rodrigues L, Pengloan J, Bourquelot P. Interventional radiology in hemodialysis fistulae and grafts: a multidisciplinary approach. Cardiovasc Intervent Radiol. Februar 2002; 25(1): 3–16.
  8. Kamper L, Haage P. Organisation of a radiological vascular access unit. J Vasc Access. 9. März 2015; 16 Suppl 9: 24–8.
  9. Haage P, Vorwerk D. Dialysis Fistulas. Complex Cases in Peripheral Vascular Interventions. New York: Informa Healthcare; 2010. S. 239–56.
  10. Mortamais J, Papillard M, Girouin N, Boutier R, Cougnaud L, Martin X, u. a. Endovascular Treatment of Juxta-anastomotic Venous Stenoses of Forearm Radiocephalic Fistulas: Long-term Results and Prognostic Factors. J Vasc Interv Radiol. 1. April 2013; 24(4): 558–64.
  11. Patanè D, Giuffrida S, Morale W, L’Anfusa G, Puliatti D, Bisceglie P, u. a. Drug-eluting balloon for the treatment of failing hemodialytic radiocephalic arteriovenous fistulas: our experience in the treatment of juxta-anastomotic stenoses. J Vasc Access. 2012; 00(0): 0–0.
  12. Turmel-Rodrigues L, Pengloan J, Baudin S, Testou D, Abaza M, Dahdah G, u. a. Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. Dezember 2000; 15(12): 2029–36.
  13. Guiu B, Loffroy R, Ben Salem D, Cercueil J-P, Aho S, Mousson C, u. a. Angioplasty of long venous stenoses in hemodialysis access: at last an indication for cutting balloon? J Vasc Interv Radiol JVIR. August 2007; 18(8): 994–1000.
  14. Dougherty MJ, Calligaro KD, Schindler N, Raviola CA, Ntoso A. Endovascular versus surgical treatment for thrombosed hemodialysis grafts: A prospective, randomized study. J Vasc Surg. Dezember 1999; 30(6): 1016–23.
  15. Karnabatidis D, Kitrou P, Spiliopoulos S, Katsanos K, Diamantopoulos A, Christeas N, u. a. Stent-grafts versus angioplasty and/or bare metal stents for failing arteriovenous grafts: a cross-over longitudinal study. J Nephrol. April 2013; 26(2): 389–95.
  16. Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, u. a. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 11. Februar 2010; 362(6): 494–503.
  17. Liang H-L, Pan H-B, Chung H-M, Ger L-P, Fang H-C, Wu T-H, u. a. Restoration of thrombosed Brescia-Cimino dialysis fistulas by using percutaneous transluminal angioplasty. Radiology. Mai 2002; 223(2): 339–44.
  18. Prologo JD, Minwell G, Kent J, Pirasteh A, Corn D. Effect of the time to intervention on the outcome of thrombosed dialysis access grafts managed percutaneously. Diagn Interv Radiol [Internet]. 5. Februar 2014 [zitiert 5. Februar 2014]; Verfügbar unter: www.dirjournal.org/summary_en_doi.php3
  19. Smits HFM, Smits JHM, Wüst AFJ, Buskens E, Blankestijn PJ. Percutaneous thrombolysis of thrombosed haemodialysis access grafts: comparison of three mechanical devices. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. März 2002; 17(3): 467–73.
  20. Shi Y, Cheng J, Song Y, Zhang J. Anatomical factors associated with left innominate vein stenosis in hemodialysis patients. Hemodial Int Int Symp Home Hemodial. 10. Januar 2014;
  21. Jaberi A, Schwartz D, Marticorena R, Dacouris N, Prabhudesai V, McFarlane P, u. a. Risk factors for the development of cephalic arch stenosis. J Vasc Access. Dezember 2007; 8(4): 287–95.
  22. Ozyer U, Harman A, Yildirim E, Aytekin C, Karakayali F, Boyvat F. Long-term results of angioplasty and stent placement for treatment of central venous obstruction in 126 hemodialysis patients: a 10-year single-center experience. AJR Am J Roentgenol. Dezember 2009; 193(6): 1672–9.
  23. Shemesh D, Goldin I, Zaghal I, Berlowitz D, Raveh D, Olsha O. Angioplasty with stent graft versus bare stent for recurrent cephalic arch stenosis in autogenous arteriovenous access for hemodialysis: a prospective randomized clinical trial. J Vasc Surg. Dezember 2008; 48(6): 1524–31, 1531.e1–2.
  24. Turmel-Rodrigues LAE. Regarding “Angioplasty with stent graft versus bare stent for recurrent cephalic arch stenosis in autogenous arteriovenous access for hemodialysis: A prospective randomized clinical trial”. J Vasc Surg. August 2009; 50(2): 472.
  25. Kamper L, Piroth W, Haage P. Endovascular treatment of dysfunctional hemodialysis catheters. J Vasc Access. Dezember 2010; 11(4): 263–8.

Hypertriglyzeridämie – Bedeutung und Therapie

Anja Vogt

  1. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011 May 24; 123(20): 2292–333.
  2. Catapano AL, Chapman J, Wiklund O, Taskinen MR. The new joint EAS/ESC guidelines for the management of dyslipidaemias. Atherosclerosis. 2011 Jul; 217(1): 1.
  3. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011 Jun; 32(11): 1345–61.
  4. Wang J, Ban MR, Zou GY, Cao H, Lin T, Kennedy BA, et al. Polygenic determinants of severe hypertriglyceridemia. Hum Mol Genet. 2008 Sep 15; 17(18): 2894–9.
  5. Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. The lancet Diabetes & endocrinology. 2014; 2(8): 655–66.
  6. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 1998; 97(11): 1029–36.
  7. Thomsen M, Varbo A, Tybjaerg-Hansen A, Nordestgaard BG. Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study. Clin Chem. 2014; 60(5): 737–46.
  8. Miller M, Cannon CP, Murphy SA, Qin J, Ray KK, Braunwald E, et al. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2008; 51(7): 724–30.
  9. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007; 298(3): 309–16.
  10. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007; 298(3): 299–308.
  11. Havel RJ. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv Intern Med. 1969; 15: 117–54.
  12. Chelland Campbell S, Moffatt RJ, Stamford BA. Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 2008; 201(2): 225–35.
  13. Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls SJ, et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet. 2010; 375(9729): 1875–84.
  14. Guo J, Meng F, Ma N, Li C, Ding Z, Wang H, et al. Meta-analysis of safety of the coadministration of statin with fenofibrate in patients with combined hyperlipidemia. Am J Cardiol. 2012; 110(9): 1296–301.
  15. Scott LJ. Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency. Drugs. 2015; 75(2): 175–82.
  16. Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? Atheroscler Suppl. 2009 D; 10(5): 49–52.